Why Gilead Sciences Stock Thrashed the Market Today The Motley Fool In drug development, solid performance in large-scale clinical trials is crucial. Gilead (GILD) Nasdaq 100 5 days
Jim Cramer On Cracker Barrel Old Country Store, Inc. (CBRL): ‘Work In Progress’ Insider Monkey 2 hours
Jim Cramer Says Regeneron Pharmaceuticals Inc. (REGN)’s Oncology Portfolio is Beautiful Insider Monkey 2 hours
Lattice Semiconductor Corporation (NASDAQ:LSCC): A Chip Stock Powering The AI Boom Insider Monkey 6 hours
Monolithic Power Systems, Inc. (NASDAQ:MPWR): A Chip Stock Powering The AI Boom Insider Monkey 6 hours
Apple pulls down Nasdaq, while Dow hits record close with Fed rate cut on the horizon YouTube 9 hours
You Won’t Believe What Larry Ellison and Elon Musk Said to Nvidia CEO Jensen Huang The Motley Fool 10 hours
These Were the 5 Biggest Companies in 1999, and Here Are the 5 Biggest Companies Now The Motley Fool 12 hours
Is OpenAI’s New Artificial Intelligence (AI) Model Bullish for Nvidia Stock? The Motley Fool 13 hours
This Beaten-Down Tech Stock Is a Coiled Spring for Decades of AI-Fueled Growth The Motley Fool 14 hours
Starbucks Corporation (SBUX): Among the Best Dividend-Paying Beverage Stocks Now Insider Monkey 14 hours
Mondelez International, Inc. (MDLZ): Among the Best Dividend-Paying Beverage Stocks Now Insider Monkey 14 hours
3 Reasons Why Adobe Stock Could Continue to Fall, and 2 Reasons It’s Still Worth Buying Now The Motley Fool 14 hours
Keurig Dr Pepper Inc. (KDP): Among the Best Dividend-Paying Beverage Stocks Now Insider Monkey 14 hours
Shopify, Fiserv, and Adyen Just Partnered With This Beaten-Down Financial Stock. Is This Good for Investors? The Motley Fool 15 hours